What is Juvenile Hyaline Fibromatosis

Juvenile Hyaline Fibromatosis (JHF) is an extremely rare, inherited connective tissue disorder characterized by the growth of abnormal, firm, non-cancerous tumors (hyaline fibromas) in the skin, joints, and bones. It typically presents in early childhood and is caused by mutations in the ANTXR2 gene, which affects how the body processes certain proteins.

What are the primary symptoms of Juvenile Hyaline Fibromatosis?

Juvenile Hyaline Fibromatosis manifests through a variety of physical symptoms that progress over time. The most notable features include skin-colored or pinkish nodules, particularly on the face, scalp, neck, and trunk. Patients with Juvenile Hyaline Fibromatosis often experience significant joint contractures (stiffness that limits movement) and gingival hypertrophy (overgrowth of the gums). Some individuals may also develop osteolytic lesions, which are areas where bone tissue is lost, potentially leading to increased fracture risk.

What causes Juvenile Hyaline Fibromatosis?

Juvenile Hyaline Fibromatosis is an autosomal recessive genetic condition, meaning a child must inherit one mutated copy of the ANTXR2 gene from each parent. This gene is responsible for producing a protein that acts as a receptor for capillary morphogenesis. When this protein is dysfunctional, the body accumulates hyaline material in the soft tissues, leading to the characteristic nodules seen in Juvenile Hyaline Fibromatosis. The condition is exceptionally rare, with fewer than 100 cases reported in medical literature worldwide.

Key clinical features of Juvenile Hyaline Fibromatosis

• Skin nodules: Firm, slow-growing tumors that may be painful.


• Gingival hypertrophy: Severe thickening of the gums, which can interfere with dental alignment and eating.


• Joint contractures: Progressive stiffness in fingers, knees, and elbows.


• Bone involvement: Lytic lesions in the bones, often identified through routine X-rays.

How is this condition distinguished from similar disorders?

Juvenile Hyaline Fibromatosis is frequently compared to Infantile Systemic Hyalinosis (ISH). While both are caused by ANTXR2 mutations, ISH is generally considered more severe, often involving internal organ damage and failure to thrive in infancy, whereas Juvenile Hyaline Fibromatosis primarily impacts the skin, joints, and skeletal system with a generally slower progression.

Next steps

• Consult a clinical geneticist to confirm the diagnosis through ANTXR2 genetic testing.


• Seek evaluation from a multidisciplinary team, including orthopedists, dentists, and dermatologists.


• Connect with the 7 members living with Juvenile Hyaline Fibromatosis on DiseaseMaps.org to share experiences and coping strategies.

Medical disclaimer: This information is for educational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician regarding a medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Juvenile Hyaline Fibromatosis.


• Orphanet: Hyaline fibromatosis syndrome (ORPHA:2167).


• OMIM (Online Mendelian Inheritance in Man): Hyaline Fibromatosis Syndrome (Entry #228600).